WinstonWınston
Neogen Chemicals Limited logo

Neogen Chemicals Limited

NEOGEN.BO
39
Chemicals - Specialty · Basic Materials
Price
₹2029.15
-3.40 (-0.17%)
Market Cap
₹53.42B
Exchange
Bombay Stock Exchange
Winston Score
39
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 9, 2026 · filings through Jun 30, 2026

Share count rising — dilution

+5.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 24.9M (2022) → 26.4M (2026)

Neogen Chemicals Limited is an Indian specialty chemicals company that makes bromine-based and lithium-based chemicals. These chemicals are used as building blocks by other industries, including pharmaceuticals, agrochemicals, and electronics. The company is one of India's leading producers of organobromide compounds and has been expanding into advanced lithium compounds used in battery materials.

Neogen earns revenue by selling these specialty chemicals to manufacturers in India and overseas, with exports playing a growing role in its business. The company operates manufacturing facilities in Gujarat, India, and generates roughly ₹500–600 crore in annual revenue, putting it in the small-cap category. Its moat comes from technical know-how in niche chemistries that are difficult to replicate quickly. The key growth driver is rising demand for lithium compounds tied to electric vehicle batteries and energy storage, but the company faces risks from high capital spending requirements and a still-low return on invested capital as new capacity ramps up.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+21.6% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+374.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (3%)

Research and development spending

Insider Activity

53.7%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$0 cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Neogen Chemicals Limited is a rare growth stock that's already generating positive cash flow while growing at 22%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
33.2%
Modest — 33.2% gross margin
Operating Margin
16.0%
Healthy — 16.0% operating margin
ROCE
1.9%
Weak — 1.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+18.0%
Fast-growing sales (+18.0% YoY)
EPS YoY
+3.9%
Modest earnings growth (+3.9% YoY)

Single-digit earnings growth — steady but not exciting.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
-692%
Weak — only -692% of profit becomes cash
FCF Margin
-45.0%
Burning cash (-45.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
1.63
Elevated debt (1.63)
Interest Cover
1.49x
Dangerous — barely covers interest (1.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
153.1x
Expensive — P/E 153.1

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+116.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (153.1 → 36.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
0.05%
Small dividend — 0.05% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
-17.6%
Dividend cut (-17.6% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial